My watch list
my.bionity.com  
Login  

Cancer Cachexia

News Cancer Cachexia

  • Molecularly shutting down cancer cachexia

    Healthy fat tissue is essential for extended survival in the event of tumor-induced wasting syndrome (cachexia). In Nature Medicine, researchers at Helmholtz Zentrum München show that selective manipulation of an enzyme can stop unwanted metabolic processes. Cancer often results in weight loss due more

  • Acacia Pharma announces positive results from Phase IIa cancer cachexia study

    Acacia Pharma announced positive results from its Phase IIa study of APD209 in cancer cachexia. APD209 comprises a new and patent protected use for an oral combination of two currently marketed drugs and has been designed to increase appetite, muscle mass and muscle function.The Phase IIa study was more

  • Santhera Licenses Melanocortin-4 Receptor Antagonist Program to BioLineRx

    Santhera Pharmaceuticals announced an exclusive license agreement with BioLineRx, covering Santhera's pre-clinical melanocortin-4 receptor (MC-4R) antagonist program currently in development for the treatment of cancer cachexia. Under the agreement, BioLineRx acquires all rights to develop, sub-lice more

All news on cancer cachexia

Publications Cancer Cachexia

All publications on cancer cachexia

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE